ASP Isotopes targets more than $300 million EBITDA by 2031 as it ramps helium output, isotope shipments
ASPI•Company outlines long-term EBITDA target
ASP Isotopes set a strategy to scale from buildout to production, targeting more than $300 million of EBITDA in 2031.
The company said the next 12 months will focus on revenue lift from liquid helium output as Virginia Gas Phase 1 completes, supported by radiopharmacy growth.
Its stable isotope division aims to start first commercial shipments, expanding the customer base as commercialization begins.
Planning continues to pursue separate public listings for Quantum Leap Energy and Noble Africa.
